Cipla has made a firm offer to the board of directors of Medpro to acquire, either through itself or through its nominated subsidiary, 100% of the ordinary shares at a price of ZAR 10.00 per share, and to settle all outstanding share options therein.

Based on Medpro’s current shares and share options outstanding, the total consideration payable by the Company or its nominated subsidiary would be approximately $512 million.

The board of directors of Medpro have recommended to its shareholders to vote in favour of the offer. Also, the independent expert appointed by the Independent board of Medpro is of the opinion the offer is fair and reasonable to the Medpro shareholders.

Cipla Share Price

1497.45 -23.10 (-1.52%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×